Concepedia

Matthew R. Trendowski

MR

Statistics

Publications

17

Citations

439

H-Index

13

Active since

2014

Affiliations

Syracuse University(Current)

University of Chicago

Vanderbilt University Medical Center

University of Pennsylvania

The Barbara Ann Karmanos Cancer Institute

Matthew R. Trendowski is an author at Syracuse University specializing in drug resistance, tumor microenvironment, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2014–2023

17

Publications

17

Using Cytochalasins to Improve Current Chemotherapeutic Approaches

Matthew R. Trendowski · Anti-Cancer Agents in Medicinal Chemistry · 2015 · 78 citations · Full text

, , +13

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

Matthew R. Trendowski, Christine M. Lusk, Julie J. Ruterbusch et al. · Cancer Medicine · 2021 · 48 citations · Full text

Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms

Omar El Charif, Brandon Mapes, Matthew R. Trendowski et al. · Clinical Cancer Research · 2019 · 42 citations · Full text

Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models

Matthew R. Trendowski, Joan M. Mitchell, Christine M. Corsette et al. · Investigational New Drugs · 2015 · 38 citations · Full text

, , +18

The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.

Matthew R. Trendowski, Guowu Yu, Victoria Wong et al. · PubMed · 2014 · 36 citations

Rows per page

1–5 of 17